GlassScriptPhysician profile
Bradford J Smith
NPI 1144271602
$4,143.75
in general payments reported to CMS, 2019-2025
38 companies · $535 in 2025
The $535 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $469 · 2020: $338 · 2021: $657 · 2022: $973 · 2023: $525 · 2024: $648 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,707.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $740.87 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $532.88 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbott Laboratories | $405.72 | 2022-2025 | Freestyle Libre 3, Proclaim |
| Pfizer INC. | $252.08 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $236.36 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $221.71 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $208.17 | 2020-2025 | Airsupra, Farxiga, Breztri |
| Janssen Pharmaceuticals, INC | $170.73 | 2019-2022 | |
| Amgen INC. | $167.97 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $152.34 | 2019-2024 | Trintellix |
| Glaxosmithkline, LLC. | $119.21 | 2019-2025 | Shingrix, Arexvy |
| Merck Sharp & Dohme LLC | $116.28 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
| Abbvie INC. | $99.90 | 2022 | |
| Amarin Pharma, INC. | $96.39 | 2019-2021 | |
| Dexcom, INC. | $71.64 | 2024-2025 | Dexcom G6 Transmitter |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradford Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.